Skip to main content

Table 1 Sociodemographic and clinical characteristics of the study participants included for analysis

From: Peripheral arterial tonometry versus polysomnography in suspected obstructive sleep apnoea

Characteristics

All (n = 940); avg ± SEM,

n (%)

Concordant (n = 748); avg ± SEM,

n (%)

Discordant (n = 192); avg ± SEM, n(%)

p-value*

Age, years

55 ± 0.4

56 ± 0.5

51 ± 1.1

< 0.0001

Gender

< 0.0001

 Male

624 (66)

518 (69)

106 (55)

 

 Body mass index, kg/m2

31 ± 0.2

32 ± 0.2

29 ± 0.4

< 0.0001

 Epworth sleepiness scale

(n = 754)

9.3 ± 0.2

9.3 ± 0.2

9.2 ± 0.4

0.735

 Time between PAT and PSG (days)

28 ± 0.7

28 ± 0.8

29 ± 1.5

0.523

Smoking status (n = 862)

0.091

 Current/ex- smoker

301 (47)/101 (11)

155 (22)/246 (36)

51 (30)/50 (29)

 

 Never smoker

360 (42)

290 (42)

70 (41)

 

 Pack years

27 ± 1.0

28 ± 1.1

24 ± 2.0

0.052

Comorbidities

847 (90)

675 (90)

172 (90)

0.785

 Arterial hypertension

534 (57)

449 (60)

85 (44)

< 0.0001

 Asthma

125 (13)

91 (12)

34 (18)

0.044

 Atrial fibrillation

58 (6)

48 (6)

10 (5)

0.806

 Cerebral vascular disease

65 (7)

55 (7)

10 (5)

0.296

 COPD

96 (10)

74 (10)

22 (11)

0.523

 Congestive heart failure

69 (7)

57 (8)

12 (6)

0.516

 Coronary artery disease

111 (12)

87 (12)

24 (13)

0.739

 Depression

147 (16)

108 (14)

39 (20)

0.046

 Diabetes mellitus

160 (17)

133 (18)

27 (14)

0.221

 Renal disease

125 (13)

110 (15)

25 (13)

0.012

 Rheumatological disease

76 (8)

61 (8)

15 (8)

0.877

  1. Comparison of patients who had discordant sleep apnoea diagnoses between PAT and PSG with patients who had concordant results between the two examinations
  2. Values in bold indicate significant p-values
  3. PAT  peripheral arterial tonometry, PSG polysomnography; COPD chronic obstructive pulmonary disease
  4. *p-value determined using Chi-square test if variable is categorical and the Mann–Whitney U-test if continuous